Ya-Min Cheng

Professor

Department of Obstetrics Gynecology

Emailchengym@mail.ncku.edu.tw

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

國立成功大學學士後醫學系學士

Research Interests

婦產科學
婦科學
婦癌學
婦科腫瘤

Fingerprint

Dive into the research topics where Ya-Min Cheng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

3 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

9 Finished

用子宮內膜及子宮頸癌疾病模式研究RAD家族基因調控與治療應用之研究
Cheng, Y.
19-08-01 → 20-07-31
Project: Research project
趨化激素受體SDF-1alfa/CXCR4及抗癌天然物在HPV病毒致癌基因E6/E7轉化之國人子宮頸癌細胞治療作用之研究
Cheng, Y.
15-08-01 → 16-07-31
Project: Research project
趨化激素受體SDF-1alfa/CXCR4及抗癌天然物在HPV病毒致癌基因E6/E7轉化之國人子宮頸癌細胞治療作用之研究
Cheng, Y.
14-08-01 → 15-07-31
Project: Research project
趨化激素受體SDF-1alfa/CXCR4及抗癌天然物在HPV病毒致癌基因E6/E7轉化之國人子宮頸癌細胞治療作用之研究
Cheng, Y.
13-08-01 → 14-07-31
Project: Research project
纖維母細胞生長因子(FGF)及其受器(FGFR)在子宮頸癌化過程中所扮演的角色
Cheng, Y.
06-08-01 → 07-07-31
Project: Research project

977 Citations
19 h-Index
54 Article
3 Letter
2 Review article
1 Comment/debate

Cytoplasmic, but not nuclear Nrf2 expression, is associated with inferior survival and relapse rate and response to platinum-based chemotherapy in non-small cell lung cancer
Chen, M. J., Lin, P. L., Wang, L., Cheng, Y. M., Chen, C. Y. & Lee, H., 2020 Jul 1, In: Thoracic Cancer. 11, 7, p. 1904-1910 7 p.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Citations (Scopus)
Real-World Study of Adding Bevacizumab to Chemotherapy for Ovarian, Tubal, and Peritoneal Cancer as Front-Line or Relapse Therapy (ROBOT): 8-Year Experience
Wu, P. Y., Cheng, Y. M., Shen, M. R., Chen, Y. C., Huang, Y. F. & Chou, C. Y., 2020 Jul 14, In: Frontiers in Oncology. 10, 1095.
Research output: Contribution to journal › Article › peer-review

Open Access
A dose escalation study of trientine plus carboplatin and pegylated liposomal doxorubicin in women with a first relapse of epithelial Ovarian, Tubal, and peritoneal cancer within 12 months after platinum-based Chemotherapy
Huang, Y. F., Kuo, M. T., Liu, Y. S., Cheng, Y. M., Wu, P. Y. & Chou, C. Y., 2019, In: Frontiers in Oncology. 9, MAY, 437.
Research output: Contribution to journal › Article › peer-review

Open Access
5 Citations (Scopus)
Longitudinal psychosocial adjustment of women to human papillomavirus infection
Hsu, Y., Wang, W., Fetzer, S. J., Cheng, Y. & Hsu, K., 2018 Nov 1, In: Journal of Advanced Nursing. 74, 11, p. 2523-2532
Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)
PSMD4 is a novel therapeutic target in chemoresistant colorectal cancer activated by cytoplasmic localization of Nrf2
Cheng, Y. M., Lin, P. L., Wu, D. W., Wang, L., Huang, C. C. & Lee, H., 2018 May 29, In: Oncotarget. 9, 41, p. 26342-26352 11 p.
Research output: Contribution to journal › Article › peer-review
8 Citations (Scopus)